Anthony S Wierzbicki (A S Wierzbicki)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 21

Top Topics

Low Density Lipoprotein

Cardiovascular Disease

Transcatheter Aortic Valve Implantation

Top Venues

International journal of clinical practice

Expert review of cardiovascular therapy

Journal of clinical pathology

Diabetic medicine : a journal of the British Diabetic Association

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony S Wierzbicki
Preventive cardiology for the aging population: how can we better design clinical trials of statins? Expert review of cardiovascular therapy (2024)
Anthony S Wierzbicki
Preventive cardiology for the aging population: how can we better design clinical trials of statins? Expert review of cardiovascular therapy 22 (1-3) (2024)
Bilal Bashir, Paul Downie, Natalie Forrester, Anthony S Wierzbicki, Charlotte Dawson, Alan Jones, Fiona Jenkinson, Michael Mansfield, Dev Datta, Hannah Delaney, Yee Teoh, Paul Hamilton, Maryam Ferdousi, See Kwok, Dawn O'Sullivan, Jian Wang, Robert A Hegele, Paul N Durrington, Handrean Soran
Ethnic Diversity and Distinctive Features of Familial Versus Multifactorial Chylomicronemia Syndrome: Insights From the UK FCS National Registry. Arteriosclerosis, thrombosis, and vascular biology (2024)
Anthony S Wierzbicki
Preventive cardiology for the aging population: how can we better design clinical trials of statins? Expert review of cardiovascular therapy 22 (1-3) (2024)
Anthony S Wierzbicki
Preventive cardiology for the aging population: how can we better design clinical trials of statins? Expert review of cardiovascular therapy (2024)
Anthony S Wierzbicki
Preventive cardiology for the aging population: how can we better design clinical trials of statins? Expert review of cardiovascular therapy 22 (1-3) (2024)
Bilal Bashir, Jan H Ho, Paul Downie, Paul Hamilton, Gordon Ferns, Dev Datta, Jaimini Cegla, Anthony S Wierzbicki, Charlotte Dawson, Fiona Jenkinson, Hannah Delaney, Michael Mansfield, Yee Teoh, Zosia Miedzybrodzka, Haya Haso, Paul N Durrington, Handrean Soran
Severe Hypertriglyceridaemia and Chylomicronaemia Syndrome-Causes, Clinical Presentation, and Therapeutic Options. Metabolites 13 (5) (2023)
Anthony S Wierzbicki, Eun Ji Kim, Oluwayemisi Esan, Radha Ramachandran
Hypertriglyceridaemia: an update. Journal of clinical pathology 75 (12) (2022)
Ahmed Handhle, Adie Viljoen, Anthony S Wierzbicki
Elevated Lipoprotein(a): Background, Current Insights and Future Potential Therapies. Vascular health and risk management 17 (2021)
Timothy M Reynolds, Anthony S Wierzbicki, Volha Skrahina, Christian Beetz, null null
Screening for patients with Gaucher's disease using routine pathology results: PATHFINDER (ferritin, alkaline phosphatase, platelets) study. International journal of clinical practice 75 (9) (2021)
Eun Ji Kim, Anthony S Wierzbicki
The history of proprotein convertase subtilisin kexin-9 inhibitors and their role in the treatment of cardiovascular disease. Therapeutic advances in chronic disease 11 (2020)
Oluwayemisi Esan, Anthony S Wierzbicki
Volanesorsen in the Treatment of Familial Chylomicronemia Syndrome or Hypertriglyceridaemia: Design, Development and Place in Therapy. Drug design, development and therapy 14 (2020)
Timothy J Reynolds, Karen L Tylee, Kathryn L Booth, Anthony S Wierzbicki, null null
Identification of patients with Fabry disease using routine pathology results: PATHFINDER (eGFR) study. International journal of clinical practice 75 (2) (2020)
Tim M Reynolds, Karen Tylee, Kathryn Booth, Anthony S Wierzbicki, null null, null null
Identification of patients with Pompé disease using routine pathology results: PATHFINDER (creatine kinase) study. Journal of clinical pathology 72 (12) (2019)
Anthony S Wierzbicki
Treating lipids in secondary prevention in a developing country: Lies, damn lies and the internet. International journal of clinical practice 73 (9) (2019)
Timothy M Reynolds, Anthony S Wierzbicki
An audit of research productivity in clinical biochemistry revisited. JRSM open 10 (4) (2019)
Anthony S Wierzbicki, Timothy M Reynolds
Primum non nocere: Demand management in pathology and preventing harm. International journal of clinical practice (2019)
Timothy M Reynolds, Anthony S Wierzbicki
Demand management of weekend haematology and clinical biochemistry requests. International journal of clinical practice (2018)
Anthony S Wierzbicki
Further options for treating lipids in people with diabetes: targeting LDL-cholesterol and beyond. Diabetic medicine : a journal of the British Diabetic Association (2018)
Anthony S Wierzbicki
Sensible economies: Demand management in blood science laboratories. International journal of clinical practice 71 (3-4) (2017)
Monika Kohli, Kinjal Patel, Zofia MacMahon, Radha Ramachandran, Martin A Crook, Timothy M Reynolds, Anthony S Wierzbicki
Pro-protein subtilisin kexin-9 (PCSK9) inhibition in practice: lipid clinic experience in 2 contrasting UK centres. International journal of clinical practice 71 (11) (2017)